Chamber and committees

How do you approach collaborating with the NHS? There are many NHS boards. Do you have to approach them one by one?

You mentioned the DAS as an appropriate alternative. There is a little bit of controversy about that, and the fact that a lot of people go into that particular arrangement without adequate financial advice.

I want to return to the issue of diligence against earnings. We have already touched on the slightly more complex way of handling family sizes and the issues around that. If the protected amount stays fixed, how could it be fairly pegged? Should it be attached to the consumer prices index? Is there a way to make it fairer?

The Scottish Government plans to lay regulations to introduce information disclosure orders and to add inhibition to the options that are available for enforcement after summary warrant. Do you have any views on the likely impact of those proposals?

I have one last question, which is probably as difficult as the one that my colleague Murdo Fraser put to you. Do you have any comments on the diligence reforms in the bill? Can you suggest any potential additions to the bill in that area?

Is it hesitancy on the part of the NHS or on the part of industry?

Less?

The pandemic drove a lot of innovative change. It would appear that the courts service and others have responded well to that. The Auditor General’s report states that remote balloting of jurors, which was part of that innovation,

“has now been made permanent”,

and that seems to make absolute sense. Are there any other changes that were introduced in response to the pandemic that either have been made permanent or you are considering making permanent?

Are there any areas in which you would like to see innovation but there are barriers to achieving it?

I have not had the benefit of seeing that review, but, presumably, it came to some conclusions about how to mitigate those impacts. Maybe you could briefly give us an overview of that.